Evidence map›Paper›PMID 29854845›Full record

ArticleJournal of immunology research2018

Three Types of Broadly Reacting Antibodies against Influenza B Viruses Induced by Vaccination with Seasonal Influenza Viruses.

Daisuke Hirano, Nobuko Ohshima, Ritsuko Kubota-Koketsu, Ayami Yamasaki, Gene Kurosawa, Yoshinobu Okuno, Shunji Yoshida, Yoshikazu Kurosawa

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Quest for a Truly Universal Influenza Vaccine.Frontiers in cellular and infection microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Daisuke HiranoSection of Rheumatology and Infectious Diseases, Department of Internal Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Nobuko OhshimaCenter for Collaboration in Research and Education, Fujita Health University, Toyoake, Aichi 470-1192, Japan.ORCID 0000-0002-9076-1879
Ritsuko Kubota-KoketsuClinical Research Section, Research Department, The Research Foundation for Microbial Disease of Osaka University, Suita, Osaka 565-0871, Japan.
Ayami YamasakiDepartment of Innovation for Advanced Medicine, Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Gene KurosawaDepartment of Academic Research Support Promotion Facility, Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Yoshinobu OkunoOsaka Institute of Public Health, Osaka, Osaka 537-0025, Japan.
Shunji YoshidaSection of Rheumatology and Infectious Diseases, Department of Internal Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Yoshikazu KurosawaDepartment of Innovation for Advanced Medicine, Center for Research Promotion and Support, Fujita Health University, Toyoake, Aichi 470-1192, Japan.
Fujita Health University · JPOsaka Prefectural Institute of Public Health · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We analyzed the antibody (Ab) repertoire against influenza B viruses induced by vaccination with seasonal influenza viruses in one individual who had never been vaccinated until 2009. The vaccine used in this study comprised B/Massachusetts/2/2012 (Yamagata lineage), A/Texas/50/2012 (H3N2), and A/California/7/2009 (H1N1). One month after the subject received two vaccinations, blood (200 ml) was obtained and peripheral mononuclear cells were prepared, and a large Ab library was constructed using phage display technology. The library was screened with HA-enriched fraction of B/Massachusetts/2/2012 and B/Brisbane/60/2008 (Victoria lineage) virus, and a total of 26 Abs that potentially bound to hemagglutinin (HA) molecules were isolated. Their binding activities to six influenza B viruses, three of Yamagata lineage and three of Victoria lineage, and two influenza A viruses, H1N1 and H3N2, were examined. The Abs showed cross-reactivity at three different levels. The first type bound to all Yamagata lineage viruses. The second type bound to both Yamagata and Victoria lineage viruses. The third type bound to both influenza A and B viruses. These results indicate that common epitopes exist on HA molecules of influenza virus at various levels, and humans have capability to produce Abs that bind to such common epitopes.

Indexed as

Antibodies, ViralCell Surface Display TechniquesCross ReactionsHEK293 CellsHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza B virusInfluenza, HumanInfluenza VaccinesNeutralization TestsReceptors, Antigen, B-CellSeasonsVaccinationAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusInfluenza VaccinesReceptors, Antigen, B-Cell

Identifiers

PMID29854845
PMCPMC5964595
OpenAlexW2800124465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.